SCHEMBL7057597

SCHEMBL7057597

O=c1ccccn1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1191487 0.71 MEN1 (0.40)
SCHEMBL642226 0.69
SCHEMBL1205563 0.69
SCHEMBL21401230 0.67
SCHEMBL7052729 0.67
SCHEMBL15923447 0.67
SCHEMBL11591369 0.67
SCHEMBL1397907 0.67
SCHEMBL2465330 0.67
SCHEMBL446051 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016830-A1 LOW TEMPERATURE STABLE FORMULATIONS OF UREASE INHIBITOR-CONTAINING COMPOSITIONS KOCH AGRONOMIC SERVICES, LLC (US) 2020-01-23 WO claimed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP claimed
EP-0370902-B1 USE OF CHROMANE DERIVATIVES IN THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DEPRESSIVE CONDITIONS ELF SANOFI (FR) 1992-08-26 EP claimed
US-5043352-A Chroman derivatives for the treatment of depressive states SANOFI (FR) 1991-08-27 US claimed
EP-4125885-B1 USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY POXEL (FR) 2024-12-25 EP disclosed
EP-4125885-C0 USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY POXEL (FR) 2024-12-25 EP disclosed
EP-3393650-B1 ELECTROCHEMICAL REACTOR TO CONTROL THE PH IN MINIATURISED DIMENSIONS LUXEMBOURG INST SCIENCE & TECH LIST (LU) 2024-08-07 EP disclosed
CN-117597327-A Pharmaceutical preparation 第一波动生物制药股份有限公司 2024-02-23 CN disclosed
EP-4125885-A1 USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY Poxel (FR) 2023-02-08 EP disclosed
EP-4125886-A1 USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHY Poxel (FR) 2023-02-08 EP disclosed
WO-2020016830-A1 LOW TEMPERATURE STABLE FORMULATIONS OF UREASE INHIBITOR-CONTAINING COMPOSITIONS KOCH AGRONOMIC SERVICES, LLC (US) 2020-01-23 WO disclosed
EP-2343069-B1 Heterocyclic aspartyl protease inhibitors MERCK SHARP & DOHME (US) 2016-03-02 EP disclosed
WO-2014151784-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2014-09-25 WO disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
US-5043352-A Chroman derivatives for the treatment of depressive states SANOFI (FR) 1991-08-27 US disclosed
US-5043352-A Chroman derivatives for the treatment of depressive states SANOFI (FR) 1991-08-27 US disclosed
EP-0370902-A2 Use of chromane derivatives in the preparation of a medicament for the treatment of depressive conditions ELF SANOFI (FR) 1990-05-30 EP disclosed